BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37812025)

  • 1. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
    Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
    Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.
    Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine M; Gundem G; Ossa JEA; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot U; You D; Mullen K; Melchor J; Ortiz MV; O'Donohue T; Slotkin E; Wexler LH; Dela Cruz FS; Hameed M; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structurally Complex Osteosarcoma Genomes Exhibit Limited Heterogeneity within Individual Tumors and across Evolutionary Time.
    Rajan S; Zaccaria S; Cannon MV; Cam M; Gross AC; Raphael BJ; Roberts RD
    Cancer Res Commun; 2023 Apr; 3(4):564-575. PubMed ID: 37066022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
    Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
    J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Informed Targeted Therapy for Osteosarcoma.
    Sayles LC; Breese MR; Koehne AL; Leung SG; Lee AG; Liu HY; Spillinger A; Shah AT; Tanasa B; Straessler K; Hazard FK; Spunt SL; Marina N; Kim GE; Cho SJ; Avedian RS; Mohler DG; Kim MO; DuBois SG; Hawkins DS; Sweet-Cordero EA
    Cancer Discov; 2019 Jan; 9(1):46-63. PubMed ID: 30266815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics and the Immune Landscape of Osteosarcoma.
    Wu CC; Livingston JA
    Adv Exp Med Biol; 2020; 1258():21-36. PubMed ID: 32767232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment.
    Brady SW; Ma X; Bahrami A; Satas G; Wu G; Newman S; Rusch M; Putnam DK; Mulder HL; Yergeau DA; Edmonson MN; Easton J; Alexandrov LB; Chen X; Mardis ER; Wilson RK; Downing JR; Pappo AS; Raphael BJ; Dyer MA; Zhang J
    Mol Cancer Res; 2019 Apr; 17(4):895-906. PubMed ID: 30651371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
    Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
    BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
    Chen X; Bahrami A; Pappo A; Easton J; Dalton J; Hedlund E; Ellison D; Shurtleff S; Wu G; Wei L; Parker M; Rusch M; Nagahawatte P; Wu J; Mao S; Boggs K; Mulder H; Yergeau D; Lu C; Ding L; Edmonson M; Qu C; Wang J; Li Y; Navid F; Daw NC; Mardis ER; Wilson RK; Downing JR; Zhang J; Dyer MA;
    Cell Rep; 2014 Apr; 7(1):104-12. PubMed ID: 24703847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
    Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
    PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
    Wang D; Niu X; Wang Z; Song CL; Huang Z; Chen KN; Duan J; Bai H; Xu J; Zhao J; Wang Y; Zhuo M; Xie XS; Kang X; Tian Y; Cai L; Han JF; An T; Sun Y; Gao S; Zhao J; Ying J; Wang L; He J; Wang J
    Cancer Res; 2019 Jan; 79(1):7-20. PubMed ID: 30389703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking the Evolution of Non-Small-Cell Lung Cancer.
    Jamal-Hanjani M; Wilson GA; McGranahan N; Birkbak NJ; Watkins TBK; Veeriah S; Shafi S; Johnson DH; Mitter R; Rosenthal R; Salm M; Horswell S; Escudero M; Matthews N; Rowan A; Chambers T; Moore DA; Turajlic S; Xu H; Lee SM; Forster MD; Ahmad T; Hiley CT; Abbosh C; Falzon M; Borg E; Marafioti T; Lawrence D; Hayward M; Kolvekar S; Panagiotopoulos N; Janes SM; Thakrar R; Ahmed A; Blackhall F; Summers Y; Shah R; Joseph L; Quinn AM; Crosbie PA; Naidu B; Middleton G; Langman G; Trotter S; Nicolson M; Remmen H; Kerr K; Chetty M; Gomersall L; Fennell DA; Nakas A; Rathinam S; Anand G; Khan S; Russell P; Ezhil V; Ismail B; Irvin-Sellers M; Prakash V; Lester JF; Kornaszewska M; Attanoos R; Adams H; Davies H; Dentro S; Taniere P; O'Sullivan B; Lowe HL; Hartley JA; Iles N; Bell H; Ngai Y; Shaw JA; Herrero J; Szallasi Z; Schwarz RF; Stewart A; Quezada SA; Le Quesne J; Van Loo P; Dive C; Hackshaw A; Swanton C;
    N Engl J Med; 2017 Jun; 376(22):2109-2121. PubMed ID: 28445112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies.
    Schott C; Shah AT; Sweet-Cordero EA
    Adv Exp Med Biol; 2020; 1258():1-19. PubMed ID: 32767231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
    Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
    Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiregional Sequencing Reveals Genomic Alterations and Clonal Dynamics in Primary Malignant Melanoma of the Esophagus.
    Li J; Yan S; Liu Z; Zhou Y; Pan Y; Yuan W; Liu M; Tan Q; Tian G; Dong B; Cai H; Wu N; Ke Y
    Cancer Res; 2018 Jan; 78(2):338-347. PubMed ID: 28972077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
    Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
    PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
    Savas P; Teo ZL; Lefevre C; Flensburg C; Caramia F; Alsop K; Mansour M; Francis PA; Thorne HA; Silva MJ; Kanu N; Dietzen M; Rowan A; Kschischo M; Fox S; Bowtell DD; Dawson SJ; Speed TP; Swanton C; Loi S
    PLoS Med; 2016 Dec; 13(12):e1002204. PubMed ID: 28027312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations.
    Lorenz S; Barøy T; Sun J; Nome T; Vodák D; Bryne JC; Håkelien AM; Fernandez-Cuesta L; Möhlendick B; Rieder H; Szuhai K; Zaikova O; Ahlquist TC; Thomassen GO; Skotheim RI; Lothe RA; Tarpey PS; Campbell P; Flanagan A; Myklebost O; Meza-Zepeda LA
    Oncotarget; 2016 Feb; 7(5):5273-88. PubMed ID: 26672768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copy-number intratumor heterogeneity increases the risk of relapse in chemotherapy-naive stage II colon cancer.
    Lahoz S; Archilla I; Asensio E; Hernández-Illán E; Ferrer Q; López-Prades S; Nadeu F; Del Rey J; Sanz-Pamplona R; Lozano JJ; Castells A; Cuatrecasas M; Camps J
    J Pathol; 2022 May; 257(1):68-81. PubMed ID: 35066875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.